SCHEMBL29174652

SCHEMBL29174652

Cn1nccc1-c1nc(Nc2cn[nH]c2)ncc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.47
JAK1 P23458 2/20 0.47
JAK3 P52333 2/20 0.47
CDK2 P24941 5/20 0.44
CCNE2 O96020 4/20 0.44
CCNE1 P24864 4/20 0.44
FLT4 P35916 2/20 0.41
KDR P35968 2/20 0.41
CCNT1 O60563 3/20 0.40
CCNB2 O95067 3/20 0.40
CDK1 P06493 3/20 0.40
CCNB1 P14635 3/20 0.40
CDK9 P50750 3/20 0.40
CDK5 Q00535 3/20 0.40
CDK5R1 Q15078 3/20 0.40
CCNB3 Q8WWL7 3/20 0.40
IGF1R P08069 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
LRRK2 Q5S007 1/20 0.38
MAPK1 P28482 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29174718 0.73 EGFR (0.57) JAK2JAK1JAK3CDK2CCNE1
SCHEMBL29174688 0.73 HDAC3 (0.47) JAK2JAK1JAK3CDK2CCNE2
SCHEMBL30725499 0.73 HDAC3 (0.47) JAK2JAK1JAK3CDK2CCNE2
SCHEMBL30725463 0.72 ALDH1A1 (0.42) CDK2CCNE2CCNE1TGFBR1TGFBR2
SCHEMBL29174633 0.72 ALDH1A1 (0.42) CDK2CCNE2CCNE1TGFBR1TGFBR2
SCHEMBL29174698 0.70 MEN1 (0.47) JAK2JAK3CDK2CCNE2CCNE1
SCHEMBL22098063 0.70 JAK2 (0.47) JAK2JAK1JAK3FLT4KDR
SCHEMBL25328688 0.69 EGFR (0.63) JAK2JAK1CDK2CCNE1KDR
SCHEMBL25329789 0.68 JAK2 (0.43) JAK2JAK1JAK3CDK2CCNE2
SCHEMBL30956630 0.68 FLT4 (0.48) JAK2JAK1JAK3FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430589-A 2-aminopyrimidine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-01-23 CN disclosed